title: Molecular dynamics studies of caspase-3.
abstract: Caspase-3 is a fundamental target for pharmaceutical interventions against a variety of diseases involving disregulated apoptosis. The enzyme is active as a dimer with two symmetry-related active sites, each featuring a Cys-His catalytic dyad and a selectivity loop, which recognizes the characteristic DEVD pattern of the substrate. Here, a molecular dynamics study of the enzyme in complex with two pentapeptide substrates DEVDG is presented, which provides a characterization of the dynamic properties of the active form in aqueous solution. The mobility of the substrate and that of the catalytic residues are rather low indicating a distinct preorganization effect of the Michaelis complex. An essential mode analysis permits us to identify coupled motions between the two monomers. In particular, it is found that the motions of the two active site loops are correlated and tend to steer the substrate toward the reactive center, suggesting that dimerization has a distinct effect on the dynamic properties of the active site regions. The selectivity loop of one monomer turns out to be correlated with the N-terminal region of the p12 subunit of the other monomer, an interaction that is also found to play a fundamental role in the electrostatic stabilization of the quaternary structure. To further characterize the specific influence of dimerization on the enzyme essential motions, a molecular dynamics analysis is also performed on the isolated monomer.
authors.affiliation: Laboratory of Computational Chemistry and Biochemistry, Federal Institute of Technology (EPFL) CH-1015 Lausanne, Switzerland.
authors.forename: M
authors.initials: M
authors.lastname: Sulpizi
authors.forename: U
authors.initials: U
authors.lastname: Rothlisberger
authors.forename: P
authors.initials: P
authors.lastname: Carloni
mesh_terms: D001665:Binding Sites; D053148:Caspase 3; D061945:Caspase Inhibitors; D020169:Caspases / Q000737:chemistry*; D003198:Computer Simulation; D003461:Crystallography / Q000379:methods*; D015853:Cysteine Proteinase Inhibitors / Q000737:chemistry*; D019281:Dimerization; D004789:Enzyme Activation; D004795:Enzyme Stability; D046911:Macromolecular Substances; D008958:Models, Molecular; D009038:Motion; D009842:Oligopeptides / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D055672:Static Electricity; D013329:Structure-Activity Relationship
chemical_list: D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors; D046911:Macromolecular Substances; D009842:Oligopeptides; C099158:acetyl-aspartyl-glutamyl-valyl-aspartal; D053148:Caspase 3; D020169:Caspases